NCT02094235View on ClinicalTrials.gov

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

E6005 0.05%

DRUG

Placebo

0.5 g placebo ointment

DRUG

E6005 0.2%

Trial Locations (3)

Unknown

Chitose-shi

Eniwa-shi

Sapporo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT02094235 - A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter